Home

Ashish Mandelia

CIK 1782805 · VP, Chief Accounting Officer · last filed 2026-01-06

Ashish Mandelia is a VP, Chief Accounting Officer who has filed 15 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for MRSN, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$156.7K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

15

Lifetime Open-Market Net

-$156.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Mersana Therapeutics, Inc. (MRSN) Delisted VP, Chief Accounting Officer 0 $29.08 $0 -$156.7K 15 2026-01-06

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-06 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed −2,300 $0 EDGAR
2025-01-17 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +5,131 -$2.1K EDGAR
2025-01-16 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +2,992 -$1.1K EDGAR
2025-01-15 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +1,639 -$665 EDGAR
2024-10-07 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +21,784 -$16.3K EDGAR
2024-02-16 Mersana Therapeutics, Inc. (MRSN) Delisted — — $0 EDGAR
2024-01-17 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +7,755 -$13.6K EDGAR
2023-09-07 Mersana Therapeutics, Inc. (MRSN) Delisted Grant (A) — $0 EDGAR
2023-01-18 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +6,561 -$20.5K EDGAR
2022-01-19 Mersana Therapeutics, Inc. (MRSN) Delisted Mixed +3,371 -$11.7K EDGAR
Showing 1–10 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.